Literature DB >> 9388387

Effects of NSAIDs on the kidney.

M D Murray1, D C Brater.   

Abstract

NSAID use is pervasive in our society. Existing NSAIDs pose little risk to patients who tolerate them early during their administration. Among persons with normal renal function who have no other risk factors (dehydration) for an acute hemodynamic effect, there is no risk. However, NSAID administration to susceptible persons may cause decrements in renal plasma flow and glomerular filtration rate within hours. This acute hemodynamic effect is the most common renal syndrome caused by NSAIDs. With careful monitoring, this effect is readily detected with routine clinical laboratory tests (serum creatinine and/or blood urea nitrogen concentrations). However, patients who continue administration of NSAIDs in this setting risk acute tubular necrosis and permanent damage to the kidney. Newer NSAIDs that selectively inhibit cyclooxygenase-2: cyclooxygenase-1 ratio may provide a more favorable risk profile for patients who cannot tolerate existing drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9388387     DOI: 10.1007/978-3-0348-8863-9_5

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


  6 in total

1.  Oral-ibuprofen-induced acute renal failure in a preterm infant.

Authors:  Omer Erdeve; S Umit Sarici; Erkan Sari; Faysal Gok
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

Review 2.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.

Authors:  Thomas Hedner; Ola Samulesson; Peter Währborg; Hans Wadenvik; Kjell-Arne Ung; Anders Ekbom
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Acute renal failure after treatment with non-steroidal anti-inflammatory drugs.

Authors:  Tim Ulinski; Vincent Guigonis; Olivier Dunan; Albert Bensman
Journal:  Eur J Pediatr       Date:  2004-01-24       Impact factor: 3.183

Review 5.  Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity.

Authors:  C H Wilder-Smith
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

6.  Acute Interstitial Nephritis and Acute Tubular Injury Due to a Transdermal Loxoprofen Patch.

Authors:  Takahiro Shinzato; Ken Ohara; Hiroaki Kaminaga; Taro Sugase; Takahiro Masuda; Daisuke Nagata; Katano Saki; Yoshitaka Kinoshita; Taro Kubo; Toshihiro Shimizu; Koji Nanmoku; Takashi Yagisawa
Journal:  Intern Med       Date:  2020-11-01       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.